Fenofibrate or omega-3 fatty acid use is associated with lower long term outcomes from propensity matched analysis of 141972 patients with diabetes in korean national health insurance cohort

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Pharmacology and Pharmacotherapy ePosters Lipid-Lowering Agents ESC Premium Access ESC Congress 2020

ESC 365 is supported by

ESC 365 is supported by